Documentos relacionados

1. The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-α2a and Oral Ribavirin.
2. Non-sustained ventricular tachycardia during treatment of genotype 3 chronic hepatitis C - a case report.
3. Safety Profile of Telaprevir-Based Triple Therapy in Elderly Patients: A Real-World Retrospective Cohort Study.
4. Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.
5. Pharmacological management of adverse events during treatment of chronic viral hepatitis in three Ivorian university hospitals
.
6. [Comparative evaluation of the effectiveness of narlaprevir in the composition of interferon and interferon-free treatment regimens for patients with chronic hepatitis C].
7. [Applying of recombinant interleukin-1ß to treat chronic hepatitis C for patients non-response to the previous antiviral therapy].
8. Pharmacological interventions for acute hepatitis C infection.
9. An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C.
10. A phase 3, open-label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin.